Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
Psychiatry and Clinical Neurosciences|March 31, 2025
Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trialXiaodong Han, Shuting Gong, Jin Gong, et al.Journal of Alzheimer'S Disease : JAD|February 19, 2015
Elevated plasma angiogenesis factors in Alzheimer's diseaseWei Qin, Xiangfei Jia, Fen Wang, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 11, 2020
Blood neuro-exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stageLongfei Jia, Min Zhu, Chaojun Kong, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's diseaseBoye Wen, Xiaodong Han, Jin Gong, et al.Asian Journal of Psychiatry|September 6, 2024
A 12-year comparison of patients with Alzheimer's dementia with their informants in eight Asian countriesKai-Ming Jhang, Pornpatr A Dharmasaroja, Vorapun Senanarong, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trialJianping Jia, Cuibai Wei, Shuoqi Chen, et al.Journal of Alzheimer'S Disease : JAD|April 23, 2026
Alterations in choroid plexus volume associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, placebo-controlled studyAidi Shan, Chang Xu, Runqi Chen, et al.The Lancet. Neurology|September 9, 2019
Dementia in China: epidemiology, clinical management, and research advancesLongfei Jia, Meina Quan, Yue Fu, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer's diseaseLongfei Jia, Yue Fu, Luxi Shen, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 19, 2015
The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trialJianping Jia, Cuibai Wei, Junhua Liang, et al.Pageof 7